drugset / Trial / NCT04437108

Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO

NCT04437108

RandomizedParallel-groupOpen-labelTreatment

Summary

comparing the outcome of low-intensity shock wave therapy (Li-SWT) versus solifenacin on persistent storage symptoms after transurethral surgery for benign prostatic obstruction (BPO)

Timeline

Start
2020-07-04
Primary completion
2022-04-12
Completion
2022-07-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 10 mg